Talk on AI and Precision Medicine from Founder and Director of Scripps Research Translational Institute
Deep learning, a subtype of artificial intelligence (AI), has considerable transformative potential to promote accuracy, streamline workflow, synthesize data for both clinicians and patients, promote patient autonomy, and greatly enhance the patient-clinician relationship. To date, however, prospective validation studies are quite limited.
Dr. Eric Topol, M.D., will discuss how we need to confront such vital issues of how AI can unintentionally worsen inequities and discrimination. The goal, which may be considered counter-intuitive, is to use this technology to make medicine more human.
Eric Topol, M.D., founder and director of the Scripps Research Translational Institute, is widely known for his development of genomic and digital tools coupled with AI analytics geared to individualize medicine.
- Pre-Cancer Atlases of Cutaneous and Hematologic OriginMarch 23, 2023Cancer Artificial Intelligence (AI) Research: Computational Approaches Addressing Imperfect DataApril 03, 2023 - April 04, 20232023 Co-Clinical Imaging Research Resource Program (CIRP) Annual Virtual MeetingMay 03, 2023 - May 04, 2023